https://www.selleckchem.com/products/bi-3406.html
Further, LC/MS analysis on ERC/mesothelin from epithelioid mesothelioma cells confirmed the presence of a bisecting-GlcNAc attached to Asn388 of ERC/mesothelin. These results suggest that this glycoproteome could serve as a potential target for the generation of a highly selective and safe therapeutic antibody for epithelioid mesothelioma.Given the huge cost, long research and development (RD) time and uncertain side effects of discovering new drugs, drug repositioning of those approved to treat diseases clinically as new drugs for
Gefällt mir
Kommentar
Teilen
